Clinical & Experimental Allergy

Nitric oxide: initiator and modulator
pp. 347-350(4)
Authors: NIJKAMP, F. P.; FOLKERTS, G.

Airway remodelling takes place in asthma — what are the clinical implications?
pp. 351-353(3)
Author: HAAHTELA, T.

Dog allergy: understanding our `best friend'?
pp. 354-357(4)
Authors: TUBIOLO, V.C.; BEALL, G. N.

Nasal nitric oxide is increased in allergic rhinitis
pp. 358-362(5)
Authors: ARNAL, J.-F.; DIDIER, A.; RAMI, J.; M'RINI, C.; CHARLET, J.-P.; SERRANO, E.; BESOMBES, J.-P.

The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway
pp. 363-371(9)
Authors: WILSON, J. W.; LI, X.

Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis
pp. 372-378(7)
Authors: FUJISHIMA, H.; TAKEYAMA, M.; TAKEUCHI, T.; SAITO, I.; TSUBOTA, K.

Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages
pp. 379-388(10)
Authors: GOSSET, P.; TILLIE-LEBLOND, I.; MALAQUIN, F.; DURIEU, J.; WALLAERT, B.; TONNEL, A.-B.

Altered compartimentalization of transforming growth factor-β in asthmatic airways
pp. 389-395(7)
Authors: MAGNAN, A.; RETORNAZ, F.; TSICOPOULOS, A.; BRISSE, J.; VAN PEE, D.; GOSSET, P.; CHAMLIAN, A.; TONNEL, A. B.; VERVLOET, D.

Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients
pp. 396-405(10)
Authors: TERAN, L. M.; CAMPOS, M. G.; BEGISHVILLI, B. T.; SCHRÖDER, J.-M.; DJUKANOVIC, R.; SHUTE, J. K.; CHURCH, M. K.; HOLGATE, S. T.; DAVIES, D. E.

Constitutive mRNA and immunoreactivity for IL-2 in human nasal mucosa
pp. 406-412(7)
Authors: MOSS, R. B.; NAGATA, H.; GOFF, J.; OKUBO, K.; HAUSEFELD, J.; KALINER, MICHAEL A.

Prevalence of latex sensitization in subjects attending health screening: implications for a perioperative screening
pp. 413-417(5)
Authors: PORRI, F.; LEMIERE, C.; BIRNBAUM, J.; GUILLOUX, L.; LANTEAUME, A.; DIDELOT, R.; VERVLOET, D.; CHARPIN, D.

The natural history of Apis-specific IgG and IgG4 in beekeepers
pp. 418-423(6)
Authors: GARCıA-ROBAINA, J. C.; DE LA TORRE-MORıN, F.; VAZQUEZ-MONCHOLI, C.; FIERRO, J.; BONNET-MORENO, C.

Purification and characterization of a soybean hull allergen responsible for the Barcelona asthma outbreaks. II. Purification and sequencing of the Gly m 2 allergen
pp. 424-430(7)
Authors: CODINA, R.; LOCKEY, R. F.; FERNÁNDEZ-CALDAS, E.; RAMA, R.

Anti-asthma effect of an antiviral drug, acyclovir: a clinical case and experimental study
pp. 431-437(7)
Authors: OKADA, H.; OHNISHI, T.; HIRASHIMA, M.; FUJITA, J.; YAMAJI, Y.; TAKAHARA, J.; TODANI, T.

Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of α₂-macroglobulin into human nasal airways
pp. 438-444(7)
Authors: GREIFF, L.; ANDERSSON, M.; SVENSSON, C.; PERSSON, C. G. A.

Microvascular actions of histamine: synergism with leukotriene B₄ and role in allergic leucocyte recruitment
pp. 445-451(7)
Authors: THORLACIUS, H.; LINDBOM, L.; HEDQVIST, P.; RAUD, J.

Localization of Charcot-Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f-Met peptide
pp. 452-474(23)
Authors: DVORAK, A. M.; MACGLASHAN, D. W.; WARNER, J. A.; LETOURNEAU, L.; MORGAN, E. S.; LICHTENSTEIN, L. M.; ACKERMAN, S. J.